Concepedia

Publication | Open Access

Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Sorafenib

DOIFull Paper Access

70

Citations

31

References

2011

Year

Ronan J. Kelly, Arun Rajan, Jeremy Force, Ariel López-Chávez, Corrine Keen, Liang Cao, Yunkai Yu, Peter L. Choyke, Barış Türkbey, Mark Raffeld,
Clinical Cancer Research

Abstract

KRAS and EGFR mutational status showed no correlation with response, PFS, or OS. Radiologic and cytokine changes may act as biomarkers indicative of early angiogenesis inhibition.

References

YearCitations

Page 1